EPSRC logo

Details of Grant 

EPSRC Reference: EP/G034656/1
Title: Industrial Doctorate Centre: Bioprocessing Engineering Leadership
Principal Investigator: Titchener-Hooker, Professor N
Other Investigators:
Mason, Professor C Dalby, Professor PA Lye, Professor G
Researcher Co-Investigators:
Project Partners:
(DO NOT USE) Nat Inst for Bio Standards Astex Therapeutics AstraZeneca
Avecia Axordia Ltd BIA Seperations
BioPharm Ltd Biovex Ltd GE Healthcare
GlaxoSmithKline plc (GSK) Health Protection Agency HEL Consultants Ltd
Lonza Biologics Merck and Co Inc Moorfields Eye Hosp NHS Foundation Trust
Novacta Biosystems Ltd Novo Nordisk A/S Onyvax Ltd
Pall Europe Ltd Pfizer Plasticell Ltd
Procter & Gamble Prometic Biosciences Ltd Protherics
TAP Biosystems UCB Unilever
Department: Biochemical Engineering
Organisation: UCL
Scheme: Centre for Doctoral Training
Starts: 01 October 2009 Ends: 31 March 2018 Value (£): 6,484,432
EPSRC Research Topic Classifications:
Design of Process systems
EPSRC Industrial Sector Classifications:
Pharmaceuticals and Biotechnology
Related Grants:
Panel History:  
Summary on Grant Application Form
The broad theme of the research training addresses the most rapidly developing parts of the bio-centred pharmaceutical and healthcare biotech industry. It meets specific training needs defined by the industry-led bioProcessUK and the Association of British Pharmaceutical Industry. The Centre proposal aligns with the EPSRC Delivery Plan 2008/9 to 2010/11, which notes pharmaceuticals as one of the UK's most dynamic industries. The EPSRC Next-Generation Healthcare theme is to link appropriate engineering and physical science research to the work of healthcare partners for improved translation of research output into clinical products and services. We address this directly. The bio-centred pharmaceutical sector is composed of three parts which the Centre will address:- More selective small molecule drugs produced using biocatalysis integrated with chemistry;- Biopharmaceutical therapeutic proteins and vaccines;- Human cell-based therapies.In each case new bioprocessing challenges are now being posed by the use of extensive molecular engineering to enhance the clinical outcome and the training proposed addresses the new challenges. Though one of the UK's most research intensive industries, pharmaceuticals is under intense strain due to:- Increasing global competition from lower cost countries;- The greater difficulty of bringing through increasingly complex medicines, for many of which the process of production is more difficult; - Pressure by governments to reduce the price paid by easing entry of generic copies and reducing drug reimbursement levels. These developments demand constant innovation and the Industrial Doctorate Training Centre will address the intellectual development and rigorous training of those who will lead on bioprocessing aspects. The activity will be conducted alongside the EPSRC Innovative Manufacturing Research Centre for Bioprocessing which an international review concluded leads the world in its approach to an increasingly important area .
Key Findings
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Potential use in non-academic contexts
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Impacts
Description This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Summary
Date Materialised
Sectors submitted by the Researcher
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Project URL:  
Further Information:  
Organisation Website: